The study will examine how Optellum’s AI technology can help radiologists at Leeds and other NHS Trusts diagnose lung cancer earlier, potentially easing pressure on radiology departments and improving outcomes for patients in Leeds and beyond.
The AI tool is designed to support radiologists in identifying lung nodules (abnormal lung growths) on CT scans more quickly and accurately. These nodules, which could be early signs of lung cancer, often require fast and careful evaluation. Early diagnosis of lung cancer can reduce patient anxiety, improve treatment options, and allow more efficient use of NHS resources.
Professor Andrew Scarsbrook, Consultant in Radiology and Nuclear Medicine at Leeds Teaching Hospitals NHS Trust said: “Optellum’s AI could be a game changer, helping us make faster and more accurate decisions about lung nodules. By identifying which cases need urgent follow-up, this technology could shorten diagnosis times and allow us to use our resources more effectively.”
Addressing the lung cancer challenge in Leeds and the UK
Lung cancer remains the leading cause of cancer-related deaths, with more than 47,000 new cases and 35,000 deaths annually in the UK. Late diagnoses are common, as lung cancer often shows no symptoms until its later stages. This study in Leeds will look at how AI can help radiologists catch these cases earlier, improving patient care and potentially saving lives.
In this study, the AI will be tested alongside Optellum’s Virtual Nodule Clinic, a digital platform designed to streamline patient care. This AI-powered system could allow Leeds radiologists and clinicians to better prioritize cases and focus on high-risk patients, ultimately improving patient care across the city and setting an example for other NHS Trusts.